21216929	207	Janku F	PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors.	Molecular cancer therapeutics	2011	127
18310287	673	Frasca F	BRAF(V600E) mutation and the biology of papillary thyroid cancer.	Endocrine-related cancer	2008	54
22941165	673	Howell GM	BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer.	Annals of surgical oncology	2013	27
24656976	1956	Yan M	HER2 aberrations in cancer: implications for therapy.	Cancer treatment reviews	2014	40
24390348	1999	Ojesina AI	Landscape of genomic alterations in cervical carcinomas.	Nature	2014	113
23852170	2064	Roberts SA	An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.	Nature genetics	2013	205
10471491	2261	Cappellen D	Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas.	Nature genetics	1999	156
26880610	2956	Dudley JC	Microsatellite Instability as a Biomarker for PD-1 Blockade.	Clinical cancer research 	2016	28
15572290	3251	DeMarini DM	Genotoxicity of tobacco smoke and tobacco smoke condensate: a review.	Mutation research	2004	95
21829508	5290	Janku F	PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers.	PloS one	2011	60
22271473	5290	Janku F	PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations.	Journal of clinical oncology 	2012	145
24910434	5290	Henderson S	APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development.	Cell reports	2014	55
9307275	5728	Tashiro H	Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies.	Cancer research	1997	127
1316611	5925	Chellappan S	Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product.	Proceedings of the National Academy of Sciences of the United States of America	1992	172
1648218	5925	Scheffner M	The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines.	Proceedings of the National Academy of Sciences of the United States of America	1991	178
23925245	6347	Adey A	The haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell line.	Nature	2013	73
19340305	6794	Wingo SN	Somatic LKB1 mutations promote cervical cancer progression.	PloS one	2009	80
9607760	7157	Storey A	Role of a p53 polymorphism in the development of human papillomavirus-associated cancer.	Nature	1998	122
12649205	7157	Pihan GA	Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas.	Cancer research	2003	102
19081593	7157	Howie HL	Papillomavirus E6 proteins.	Virology	2009	77
25538195	7157	Vieira VC	Human papillomavirus E6 triggers upregulation of the antiviral and cancer genomic DNA deaminase APOBEC3B.	mBio	2014	33
21882293	23405	Foulkes WD	Extending the phenotypes associated with DICER1 mutations.	Human mutation	2011	37
23482656	100507436	Chen D	Genome-wide association study of susceptibility loci for cervical cancer.	Journal of the National Cancer Institute	2013	29
